Press release
July 29, 2026
TriSalus Life Sciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
TriSalus Life Sciences, Inc. (TLSI)
WESTMINSTER, Colo. --(BUSINESS WIRE)--Jul. 29, 2026-- TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, today announced that Mary